OptimizeRx Corp — Director's Dealing 2014

Jan 28, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2014-01-28

Reporting Person: Lester David (Director, COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-28	Common Stock	C	410348	$1.952	Acquired	428348	Direct

Footnotes

F1: The Reporting Person has elected to convert 500,000 stock options through a cashless exercise into common stock of the Issuer.